The core activity of Eusyna GmbH is to advise and support companies in introducing pharmaceutical and medical products to the Chinese market. This includes, in particular: Regulatory Affairs (e.g. support with NMPA inspections in Europe), market launch (e.g. acquisition of distribution partners, conduct of clinical trials), mediation between companies and Chinese authorities, and support in communication with Chinese partners and authorities, taking into account differences in mentality and culture. Eusyna GmbH positions itself as a LifeScience consulting company, specifically supporting small and medium-sized enterprises in accessing the Chinese market.